Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
3.020
-0.100 (-3.21%)
At close: Jul 10, 2025, 4:00 PM
2.990
-0.030 (-0.99%)
Pre-market: Jul 11, 2025, 4:24 AM EDT

Bone Biologics Statistics

Total Valuation

Bone Biologics has a market cap or net worth of $4.85 million. The enterprise value is $2.10 million.

Market Cap 4.85M
Enterprise Value 2.10M

Important Dates

The next estimated earnings date is Friday, August 8, 2025, after market close.

Earnings Date Aug 8, 2025
Ex-Dividend Date n/a

Share Statistics

Bone Biologics has 1.61 million shares outstanding. The number of shares has increased by 421.86% in one year.

Current Share Class 1.61M
Shares Outstanding 1.61M
Shares Change (YoY) +421.86%
Shares Change (QoQ) +28.35%
Owned by Insiders (%) 0.04%
Owned by Institutions (%) 0.37%
Float 1.45M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.57
P/TBV Ratio 1.67
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 12.59

Current Ratio 12.59
Quick Ratio 10.94
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -129.48% and return on invested capital (ROIC) is -82.64%.

Return on Equity (ROE) -129.48%
Return on Assets (ROA) -77.73%
Return on Invested Capital (ROIC) -82.64%
Return on Capital Employed (ROCE) -149.58%
Revenue Per Employee n/a
Profits Per Employee -$3.74M
Employee Count 2
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -54.24% in the last 52 weeks. The beta is 1.22, so Bone Biologics's price volatility has been higher than the market average.

Beta (5Y) 1.22
52-Week Price Change -54.24%
50-Day Moving Average 4.55
200-Day Moving Average 6.39
Relative Strength Index (RSI) 34.93
Average Volume (20 Days) 1,483,903

Short Selling Information

The latest short interest is 29,866, so 1.86% of the outstanding shares have been sold short.

Short Interest 29,866
Short Previous Month 200,038
Short % of Shares Out 1.86%
Short % of Float 2.06%
Short Ratio (days to cover) 0.46

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -4.35M
Pretax Income -5.12M
Net Income -7.48M
EBITDA n/a
EBIT -4.35M
Earnings Per Share (EPS) -$20.88
Full Income Statement

Balance Sheet

The company has $2.75 million in cash and n/a in debt, giving a net cash position of $2.75 million or $1.71 per share.

Cash & Cash Equivalents 2.75M
Total Debt n/a
Net Cash 2.75M
Net Cash Per Share $1.71
Equity (Book Value) 2.91M
Book Value Per Share 5.34
Working Capital 2.91M
Full Balance Sheet

Cash Flow

Operating Cash Flow -3.75M
Capital Expenditures n/a
Free Cash Flow -3.75M
FCF Per Share -$2.33
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Bone Biologics does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -421.86%
Shareholder Yield -421.86%
Earnings Yield -154.21%
FCF Yield -77.30%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on June 10, 2025. It was a reverse split with a ratio of 0.1666667:1.

Last Split Date Jun 10, 2025
Split Type Reverse
Split Ratio 0.1666667:1

Scores

Altman Z-Score n/a
Piotroski F-Score 1